Ridgewood Investments’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $372K | Buy |
+2,666
| New | +$373K | 0.15% | 163 |
|
|
2025
Q3 | $510K | Sell |
4,596
-61
| -1% | -$6.93K | 0.22% | 127 |
|
|
2025
Q2 | $516K | Sell |
4,657
-4,045
| -46% | -$430K | 0.22% | 112 |
|
|
2025
Q1 | $975K | Sell |
8,702
-2,306
| -21% | -$238K | 0.46% | 64 |
|
|
2024
Q4 | $1.02M | Sell |
11,008
-2,364
| -18% | -$213K | 0.49% | 65 |
|
|
2024
Q3 | $1.12M | Sell |
13,372
-1,426
| -10% | -$109K | 0.56% | 55 |
|
|
2024
Q2 | $1.02M | Buy |
14,798
+7,991
| +117% | +$533K | 0.51% | 55 |
|
|
2024
Q1 | $499K | Buy |
+6,807
| New | +$523K | 0.26% | 119 |
|
|
2023
Q3 | – | Sell |
-180
| Closed | -$13.9K | – | 409 |
|
|
2023
Q2 | $13.9K | Sell |
180
-589
| -77% | -$47K | 0.01% | 484 |
|
|
2023
Q1 | $63.8K | Sell |
769
-11,532
| -94% | -$955K | 0.04% | 305 |
|
|
2022
Q4 | $1.06M | Sell |
12,301
-10,792
| -47% | -$855K | 0.75% | 33 |
|
|
2022
Q3 | $1.43M | Sell |
23,093
-8
| -0% | -$504 | 1.19% | 16 |
|
|
2022
Q2 | $1.43M | Sell |
23,101
-1
| -0% | -$62 | 1.12% | 14 |
|
|
2022
Q1 | $1.37M | Sell |
23,102
-475
| -2% | -$30.4K | 0.9% | 17 |
|
|
2021
Q4 | $1.71M | Buy |
23,577
+464
| +2% | +$32K | 1.09% | 13 |
|
|
2021
Q3 | $1.61M | Sell |
23,113
-9
| -0% | -$632 | 1.09% | 15 |
|
|
2021
Q2 | $1.59M | Buy |
23,122
+4,252
| +23% | +$284K | 1.02% | 16 |
|
|
2021
Q1 | $1.22M | Buy |
18,870
+5,960
| +46% | +$384K | 0.75% | 37 |
|
|
2020
Q4 | $816K | Hold |
12,910
| – | – | 0.64% | 42 |
|
|
2020
Q3 | $816K | Buy |
12,910
+6,385
| +98% | +$443K | 0.64% | 43 |
|
|
2020
Q2 | $502K | Sell |
6,525
-617
| -9% | -$47.3K | 0.42% | 86 |
|
|
2020
Q1 | $534K | Sell |
7,142
-10,420
| -59% | -$720K | 0.54% | 55 |
|
|
2019
Q4 | $1.14M | Buy |
17,562
+1,906
| +12% | +$124K | 0.81% | 23 |
|
|
2019
Q3 | $992K | Buy |
15,656
+2,474
| +19% | +$162K | 0.77% | 28 |
|
|
2019
Q2 | $891K | Buy |
13,182
+4,992
| +61% | +$328K | 0.7% | 34 |
|
|
2019
Q1 | $532K | Buy |
8,190
+1,701
| +26% | +$113K | 0.44% | 62 |
|
|
2018
Q4 | $501K | Hold |
6,489
| – | – | 0.4% | 69 |
|
|
2018
Q3 | $501K | Buy |
6,489
+490
| +8% | +$37K | 0.4% | 69 |
|
|
2018
Q2 | $425K | Buy |
5,999
+534
| +10% | +$37.7K | 0.38% | 80 |
|
|
2018
Q1 | $412K | Buy |
5,465
+428
| +8% | +$34K | 0.38% | 78 |
|
|
2017
Q4 | $361K | Buy |
5,037
+743
| +17% | +$56.4K | 0.32% | 95 |
|
|
2017
Q3 | $348K | Sell |
4,294
-60
| -1% | -$4.59K | 0.33% | 93 |
|
|
2017
Q2 | $308K | Buy |
4,354
+858
| +25% | +$57.1K | 0.31% | 98 |
|
|
2017
Q1 | $237K | Buy |
+3,496
| New | +$246K | 0.25% | 112 |
|
Other funds holding GILD
VCM
VPM
Ridgewood Investments's GILD Position: Q1 2026 in Review
Ridgewood Investments opened a new position in Gilead Sciences (GILD) in Q1 2026: 2,666 shares worth $372K. The stake represents 0.15% of the portfolio and ranks #163 among its holdings. This is a return to the name: Ridgewood Investments previously reported a position in GILD as recently as Q3 2025.
Ridgewood Investments first reported a position in GILD in Q1 2017 and has held it in 34 quarters since. The position peaked at $1.71M in Q4 2021. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Ridgewood Investments held 2,666 shares of Gilead Sciences worth $372K as of Q1 2026.
- Gilead Sciences was a new Ridgewood Investments position in Q1 2026.
- Gilead Sciences made up 0.15% of Ridgewood Investments's portfolio in Q1 2026, its #163 holding.
- Ridgewood Investments first reported a position in Gilead Sciences in Q1 2017 and has held it in 34 quarters since.
- Ridgewood Investments's Gilead Sciences position peaked at $1.71M in Q4 2021.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Ridgewood Investments's 13F filing for Q1 2026, filed 3 Apr 2026.